MORINI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 1.166
EU - Europa 1.101
AS - Asia 472
AF - Africa 22
OC - Oceania 1
Totale 2.762
Nazione #
US - Stati Uniti d'America 1.142
CN - Cina 343
FI - Finlandia 324
SE - Svezia 240
IE - Irlanda 205
UA - Ucraina 135
DE - Germania 122
SG - Singapore 67
TR - Turchia 54
GB - Regno Unito 27
CA - Canada 24
CI - Costa d'Avorio 22
BE - Belgio 19
IT - Italia 18
IN - India 5
AT - Austria 4
CZ - Repubblica Ceca 3
IR - Iran 3
AU - Australia 1
EE - Estonia 1
ES - Italia 1
FR - Francia 1
NL - Olanda 1
Totale 2.762
Città #
Chandler 222
Dublin 205
Jacksonville 187
Ann Arbor 108
Dearborn 86
Beijing 58
Nanjing 58
Izmir 54
New York 52
Ashburn 50
Boardman 50
Shanghai 40
Singapore 40
Princeton 37
San Mateo 29
Toronto 23
Abidjan 22
Jinan 21
Brussels 19
Hebei 19
Bremen 18
Wilmington 18
Hefei 17
Nanchang 17
Des Moines 15
Helsinki 13
Shenyang 13
Grafing 12
Kunming 11
Tianjin 10
Changsha 9
Houston 9
Seattle 8
Guangzhou 7
Los Angeles 7
Santa Clara 7
Woodbridge 7
Haikou 6
Jiaxing 6
Hangzhou 5
Norwalk 5
Dallas 4
Taiyuan 4
Vienna 4
Auburn Hills 3
Augusta 3
Brno 3
Milan 3
Munich 3
Ningbo 3
Parma 3
Sabz 3
Zhengzhou 3
Borås 2
Fremont 2
Fuzhou 2
Leipzig 2
Magdeburg 2
Pune 2
Baotou 1
Bari 1
Canberra 1
Charlotte 1
Chengdu 1
Chongqing 1
Dundee 1
Düsseldorf 1
Frankfurt am Main 1
Jinhua 1
La Canada Flintridge 1
Lanzhou 1
London 1
Madison 1
Madrid 1
Mountain View 1
Mumbai 1
New Delhi 1
Piacenza 1
Redmond 1
Stevenage 1
Taizhou 1
Tallinn 1
Turate 1
Wuhan 1
Xian 1
Totale 1.677
Nome #
Effect of Cl-Substitution on Rooting- or Cytokinin-like Activity of Diphenylurea Derivatives 105
Azionifarmacologiche di composti alchilaminoalchilfenilbenzisotiazolici sul trattogastrointestinale 104
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 96
Synthesis and 3D-QSAR Analysis of H3 Receptor Antagonists Containing a Neutral Heterocyclic Polar Group 91
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 86
Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups 86
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 84
4-(1,2-benzisothiazol-3-)alkanoic and phenylalkanoic acids: synthesis and anti-inflammatory, analgesic and antipyretic activities 82
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 79
Action of histamine and ofdifferent synthetic P^ receptor stimulants on the isolated gastric fundus of theguinea pig 78
HPLC detection ofthioperamide from biological samples and its determination in rat blood and brainafter systemic administration 77
Diheteroarylurea derivatives as adventitious rooting adjuvants in mung bean shoots and M26 apple rootstock. 76
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 76
Cytokinin-like activity of N,N'-diphenylureas. N,N'-bis-(2,3-methylenedioxyphenyl)urea and N,N'-bis-(3,4-methylenedioxyphenyl)urea enhance adventitious root formation in apple rootstock M26 (Malus pumila Mill) 74
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 74
Antiulcer long-term treatment in chronic ulcer rat 73
4-(3-Oxo-1,2-benzisothiazolin-2-yl)alkanoic, phenyl and phenoxyalkanoic acids: synthesis and anti-inflammatory, analgesic, and antipyretic properties 72
A possible physiological role ofhistamine H^-receptors in rat mesenteric circulation 71
Hz-agonistiimidazolici: importanza della 2-amino sostituzione per 1'attivita farmacologica 71
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 70
Heteroarylaminoethyl and heteroarylthioethylimidazoles. Synthesis and H3-receptor affinity 70
H3-antagonists: synthesis and activity of 2-amino-5-thiazolyl derivatives 70
The anti-H1-histaminic and antimuscarinic effect of 2- and 4-[benzyl-(2-dimethylaminoethyl)amino]pyrimidine compounds]. 69
Biological studies on 1,2-benzisothiazole derivatives. V. Antimicrobial properties of N-alkanoic, N-arylalkanoic and N-aryloxyalkanoic derivatives of 1,2-benzisothiazolin-3-one: QSAR study and genotoxicity evaluation 69
Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: preliminary pharmacological investigation. 68
Pharmacological activities of two new histamine analogs 66
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 66
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 65
Histamine H3-antagonists: the basicity of the polar group in quantitative structure-activity and structure-property relationship 65
Liquid chromatography-mass spectrometric method for determination of the non-imidazole H(3) -receptor antagonist UPR1056 in rat plasma. 63
null 61
Studio di sostanze analoghe alDimaprit sulla secrezione gastrica "in vitro" 59
Influence of urea-equivalent groups in position 5 of 2-amino, 2-(1-aminoethylidenamino) and 2-guanidino thiazole derivatives on H3-receptor antagonist activity in gastric fistula cat 56
Rat protein binding and cerebral phospholipid affinity of the H3-receptor antagonist thioperamide 55
Synthesis of benzisoxazole and benzisothiazole derivatives with potential antitumor activity 53
Synthesis and binding assays of H3-receptor ligands. 53
In vitro pharmacology at human histamine H(3) receptors and brain access of non-imidazole alkylpiperidine derivatives. 50
Antipyreticactivity of new compounds 4-(3-oxo-l,2-benzisothiazolin-2-yl)puenyialkanoicacids, their esters, amides and 1,1 dioxide derivatives 38
null 37
Are histamine receptors involved in the stimulant activities ofthiazolylethylamines supposed as cyclic models of dimaprit? 12
Totale 2.770
Categoria #
all - tutte 9.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.725


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020390 0 0 0 9 52 64 84 10 70 28 33 40
2020/2021278 5 41 19 8 40 1 33 1 65 5 58 2
2021/2022206 5 1 4 19 12 16 26 28 10 12 14 59
2022/2023815 100 98 59 53 79 92 17 45 241 5 20 6
2023/2024264 16 27 4 7 17 92 25 11 10 9 15 31
2024/2025139 36 44 55 4 0 0 0 0 0 0 0 0
Totale 2.770